NCT07378397

Brief Summary

Magnetoencephalography, or "MEG", is a brain-scanning method which has been available for many years. It is used in the UK and worldwide to help patients with epilepsy, who need surgery to resolve their seizures. The MEG scan can help inform the surgeon about where to operate, by mapping the abnormal brain activity caused by epilepsy. During a traditional MEG recording, patients sit very still with their head in a rigid helmet which houses many tiny sensors. This can be uncomfortable, and there are additional problems if the patient is a child, because the helmet is often too big. It is not possible to record useful data from the very youngest children with a traditional MEG scanner. But there is a new generation of MEG systems, called OPM-MEG, which employ lightweight sensors housed in a kind of hat. The hat can be appropriately sized for children, and the patient can move comfortably. The new systems are also more cost-effective to run. It is important to know whether the accepted clinical protocols for using MEG in planning epilepsy surgery can be directly transferred to OPM-MEG. It is also important to understand how the patient experience compares across systems. In this project, 20 volunteer patients will be recruited from among those children already having routine pre-surgical MEG recordings Aston University. They will be invited to participate in an OPM-MEG recording in the same facility at Aston University, so that data from the new OPM-MEG device can be compared with the data from the old MEG scanner. Data analysis pipelines will be streamlined, and the accuracy of the results compared to determine whether the improved sensor arrangement for children in the OPM-MEG system leads to better localisation of epileptiform activity.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
17mo left

Started Jun 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jun 2025Sep 2027

Study Start

First participant enrolled

June 17, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 19, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 30, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 19, 2026

Last Update Submit

January 27, 2026

Conditions

Keywords

OPM-MEGmagnetoencephalography

Outcome Measures

Primary Outcomes (1)

  • Comparative localisations of epileptiform activity

    Interictal epileptiform activity recorded in the OPM-MEG data will be localised with standard techniques, and resulting brain activity maps compared with those obtained in cryogenic MEG data that is shared into the study.

    Within 3 months of referral

Study Arms (1)

Children with epilepsy

Children with refractory epilepsy who are candidates for neurosurgery and have been referred for a clinical MEG scan.

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population is all children who are in the care of Birmingham Children's Hospital Epilepsy Surgery Service, who have been referred to Aston University for a clinical MEG scan as candidates for neurosurgery.

You may qualify if:

  • Patients who are capable of giving informed assent, and have a person with parental responsibility capable of giving informed consent on their behalf.
  • Male or female.
  • Patients between the age of 6-15 years
  • Patients and caregivers with English language skills that enable informed assent/consent.

You may not qualify if:

  • Patients, or parent or caregiver, who do not assent or consent to participate in the research either on that day or later.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aston University

Birmingham, United Kingdom, B4 7ET, United Kingdom

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Caroline WITTON, PhD

    Aston University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2026

First Posted

January 30, 2026

Study Start

June 17, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

January 30, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

This is essentially a qualitative proof of concept study and data may not be of the required quality for sharing.

Locations